The effects of Deng Zhan Sheng Mai capsule on secondary and tertiary prevention of ischemic stroke

Chen Biao, F. Xianghua, Wu Yong-hao, Jin Song-ling, Liu Hong-jun, Li Shu-ting
{"title":"The effects of Deng Zhan Sheng Mai capsule on secondary and tertiary prevention of ischemic stroke","authors":"Chen Biao, F. Xianghua, Wu Yong-hao, Jin Song-ling, Liu Hong-jun, Li Shu-ting","doi":"10.3321/J.ISSN:1006-7876.2008.03.015","DOIUrl":null,"url":null,"abstract":"Objective To evaluate the effects of Deng Zhan Sheng Mai (DZSM) capsule, a compound made of Chinese herbs, on secondary and tertiary prevention of ischemic stroke. Methods A hospital-based randomized open-blinded clinical trial was conducted among people with a prior history of ischemic stroke. Hospitals were assigned to treatment group, in which all of the participants took DZSM capsules for 3 months, or control group, in which no DZSM capsules was administrated. The primary endpoint was the reduction of levels of blood lipids, fasting blood glucose (FBG) and fibrinogen in the 3rd month. The secondary endpoints were recurrence of stroke, incidence of cardiovascular event (CVD) and all-cause mortality in the 18th month. Results 495 people were enrolled in the treatment group and 504 in the control group, respectively. In the 3rd month, the levels of total cholesterol(TC),FBG and fibrinogen were significantly reduced by 1.7%,4.3 and 8.2%(t values were 4.13,6.65 and 8.50 respectively),and the levels of HDL-C and HDL-C/TC were increased by 7.6%and 1 1.6%(t values were 2.15 and 3.67)in the treatment group, respectively(all P<0.05=.The levels of TC,HDL-C and HDL-C/TC decreased significantly in the eontrol group(all P<0.05=.The incidence of recurrent stroke and CVD events were lower in the treatment group than those in the control group, but the differences did not reach the significant levels. The prevalence of post-stroke depression (PSD) was also decreased in the 3rd mouth while it remained stable in the controls (P for trend equals to 0.0027). The mortality was significantly lower in the treatment group (P=0.008). Conclusion The levels of TC,FBG and fibrinogen as well as the prevalence of PSD and all-cause mortality have decreased significantly in treatment group treated with DZSM capsule for 3 months as compared with the control group. \n \nKey words: \nBrain ischemia;  Cerebrovascular accident;  Erigeron breviscapua;  Randomized controlled trials","PeriodicalId":10143,"journal":{"name":"中华神经科杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华神经科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3321/J.ISSN:1006-7876.2008.03.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Objective To evaluate the effects of Deng Zhan Sheng Mai (DZSM) capsule, a compound made of Chinese herbs, on secondary and tertiary prevention of ischemic stroke. Methods A hospital-based randomized open-blinded clinical trial was conducted among people with a prior history of ischemic stroke. Hospitals were assigned to treatment group, in which all of the participants took DZSM capsules for 3 months, or control group, in which no DZSM capsules was administrated. The primary endpoint was the reduction of levels of blood lipids, fasting blood glucose (FBG) and fibrinogen in the 3rd month. The secondary endpoints were recurrence of stroke, incidence of cardiovascular event (CVD) and all-cause mortality in the 18th month. Results 495 people were enrolled in the treatment group and 504 in the control group, respectively. In the 3rd month, the levels of total cholesterol(TC),FBG and fibrinogen were significantly reduced by 1.7%,4.3 and 8.2%(t values were 4.13,6.65 and 8.50 respectively),and the levels of HDL-C and HDL-C/TC were increased by 7.6%and 1 1.6%(t values were 2.15 and 3.67)in the treatment group, respectively(all P<0.05=.The levels of TC,HDL-C and HDL-C/TC decreased significantly in the eontrol group(all P<0.05=.The incidence of recurrent stroke and CVD events were lower in the treatment group than those in the control group, but the differences did not reach the significant levels. The prevalence of post-stroke depression (PSD) was also decreased in the 3rd mouth while it remained stable in the controls (P for trend equals to 0.0027). The mortality was significantly lower in the treatment group (P=0.008). Conclusion The levels of TC,FBG and fibrinogen as well as the prevalence of PSD and all-cause mortality have decreased significantly in treatment group treated with DZSM capsule for 3 months as compared with the control group. Key words: Brain ischemia;  Cerebrovascular accident;  Erigeron breviscapua;  Randomized controlled trials
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
邓盏生脉胶囊对缺血性脑卒中二、三级预防的影响
目的评价中药复方邓湛生脉胶囊对缺血性脑卒中的二级和三级预防作用。方法在有缺血性脑卒中病史的患者中进行随机、开放、盲法临床试验。将医院分为治疗组和对照组,治疗组所有患者服用DZSM胶囊3个月,对照组不服用DZSM胶囊。主要终点是在第3个月内血脂、空腹血糖(FBG)和纤维蛋白原水平的降低。次要终点为18个月内卒中复发率、心血管事件(CVD)发生率和全因死亡率。结果治疗组495人,对照组504人。第3个月,治疗组总胆固醇(TC)、空腹血糖(FBG)和纤维蛋白原水平分别显著降低1.7%、4.3%和8.2%(t值分别为4.13、6.65和8.50),HDL-C水平和HDL-C/TC水平分别显著升高7.6%和11.6% (t值分别为2.15和3.67)(P均<0.05=)。对照组患者TC、HDL-C及HDL-C/TC水平均显著降低(P<0.05)。治疗组卒中复发及CVD事件发生率均低于对照组,但差异未达到显著水平。卒中后抑郁(PSD)患病率在第3个月也有所下降,而在对照组保持稳定(趋势P = 0.0027)。治疗组病死率明显低于对照组(P=0.008)。结论与对照组相比,治疗组治疗3个月后TC、FBG、纤维蛋白原水平、PSD患病率及全因死亡率均明显降低。关键词:脑缺血;脑血管意外;飞蓬属植物breviscapua;随机对照试验
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中华神经科杂志
中华神经科杂志 Medicine-Neurology (clinical)
CiteScore
0.70
自引率
0.00%
发文量
6868
期刊介绍:
期刊最新文献
Acute necrotizing encephalitis caused by respiratory coronavirus-NL63: a case report A case of coronavirus disease 2019 with tuberculous meningitis Investigation of the mental health of patients with novel coronavirus pneumonia/ 中华神经科杂志 The clinical, imaging, intestinal pathological characteristics of gluten ataxia: a case report in Chinese mainland Study on CT perfusion surface permeability of cerebral hemorrhage in the basal ganglia region in subacute stage
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1